Katherine Van Loon, MD, MPH

Gastrointestinal oncologist

Dr. Katherine Van Loon is a gastrointestinal cancer specialist, with a particular interest in colon cancer. Van Loon received a master's degree in public health (M.P.H.) from the Yale University School of Epidemiology and Public Health before attending the Medical College of Georgia. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center, Harvard Medical School. She came to UCSF for her fellowship in oncology in 2009.

With her background in public health, Van Loon's research is focused on epidemiology and outcomes research in gastrointestinal malignancies. She has a longstanding interest in global health, and her research has also focused on the epidemiology of gastrointestinal cancers in the developing world.

Van Loon is a member of the American Society of Clinical Oncology. She received a Young Investigator Award from the ASCO Conquer Cancer Foundation in 2012.

Clinics

Gastrointestinal Medical Oncology Clinic
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Phone: (415) 353-9888
Fax: (415) 353-9931

Hours: Monday to Friday
8 a.m. – 5 p.m.

Gastrointestinal Oncology Survivorship Program
1825 Fourth St., Fourth Floor
San Francisco, CA 94143
Phone: (415) 353-9888
Fax: (415) 353-9931

Pancreas Center
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Patient Information and Appointments: (415) 353-9888
Administrative Inquiries: (415) 476-3270
Fax: (415) 353-9931

Hours: Monday to Friday
8 a.m. — 5 p.m.

Conditions & Treatments

Board Certification

Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine

Academic Title

Associate Professor

More about Katherine Van Loon

Education

Medical College of Georgia 2006

Residencies

Beth Israel Deaconess Medical Center, Harvard Medical School, Internal Medicine 2009

Fellowships

UCSF Medical Center, Oncology 2011

Selected Research and Publications

  1. Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, You YN, Kozower BD, Greenberg CC, Schrag D, Venook A, McKellar D, Winchester DP, Chang GJ. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. JAMA. 2018 May 22; 319(20):2104-2115.
  2. Ursem C, Atreya CE, Van Loon K. Emerging treatment options for BRAF-mutant colorectal cancer. Gastrointest Cancer. 2018; 8:13-23.
  3. Van Loon K, Mwachiro MM, Abnet CC et al.. The African Esophageal Cancer Consortium: A Call to Action. Journal of Global Oncology. 2018.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.